Thermo Fisher Scientific Inc. news

   Watch this stock
Showing stories 1 - 10 of about 118   

Articles published

TMO 191.00 +0.83 (0.44%)
price chart
Thermo Fisher Scientific Inc (TMO) CEO Marc N Casper Sold $9.4 million of Shares
Thermo Fisher Scientific Inc has a market cap of $76.26 billion; its shares were traded at around $190.17 with a P/E ratio of 32.29 and P/S ratio of 3.82.
Analyst Observation On 2 Stocks: Thermo Fisher Scientific Inc. (TMO ...  Post Analyst
Thermo Fisher Scientific Inc (TMO) Holdings Reduced by Cornerstone Capital ...  The Ledger Gazette
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass., Nov. 9, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend of $0.15 per share.
Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific  GlobeNewswire (press release)
Thermo Fisher Scientific Inc. acquires Patheon NV for US$7.2B  Lexpert, a Thomson Reuters Business
Thermo Fisher Scientific Signs Oncology Companion Diagnostic Development ...
CARLSBAD, Calif., Oct. 31, 2017 /PRNewswire/ -- As part of its ongoing commitment to increase the utility of next-generation sequencing (NGS) in the clinic, Thermo Fisher Scientific announced today it has expanded the development of its Oncomine Dx ...
Revenue Approximations Analysis: Thermo Fisher Scientific Inc. (TMO), ITT ...  StockNewsJournal
Analyst Commentary On Thermo Fisher Scientific Inc. (TMO), MyoKardia, Inc ...  Post Analyst
Changes in Signals Identified: Monsanto Company (MON), Thermo Fisher ...
Monsanto Company (NYSE:MON) trades at $118.33 having a market capitalization of $52.21 billion. MON stock price climbed 17.55% over the past year, yielding a positive weighted alpha of 13.5 percent.
Thermo Fisher Scientific and Cellular Biomedicine Group Announce Strategic ...
SHANGHAI, China and CUPERTINO, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a leading clinical-stage biopharmaceutical firm engaged in the development of ...
Thermo Fisher Scientific (TMO) Q3 2017 Results - Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2017 third quarter conference call. All lines have been placed on mute to prevent any background noise.
Thermo Fisher Scientific Reports Third Quarter 2017 Results  PR Newswire (press release)
Thermo Fisher tops profit estimates; raises full-year forecast  Reuters
Americafirst Capital Management, Llc Buys Sysco Corp, Exelon Corp, Thermo ...
Americafirst Capital Management, Llc initiated holdings in Biogen Inc. The purchase prices were between $271.76 and $329.69, with an estimated average price of $295.47.
Thermo Fisher Scientific Inc (TMO) Moves Lower on Volume Spike for November 10
Thermo Fisher Scientific Inc (TMO) traded on unusually high volume on Nov. 10, as the stock lost 2.98% to close at $186.18.
California Public Employees Retirement System Sells 2700 Shares of Thermo ...  The Ledger Gazette
Thermo Fisher Scientific Inc (NYSE:TMO) Downgraded by Zacks Investment Research  Dispatch Tribunal
Quant Score Makes Thermo Fisher Scientific (TMO) a Buy
Portfolio Grader currently ranks Thermo Fisher Scientific Inc (NYSE:TMO) a Buy. The methodology for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and ...
Is Thermo Fisher Scientific Inc (TMO) Worth $193.71 Based On Its Intrinsic ...  Simply Wall St
Thermo Fisher Scientific Inc (NYSE:TMO) Shares Sold by UBS Asset Management ...  The Ledger Gazette
Earnings Visibility Keep Thermo Fisher Scientific (TMO) a Buy
Thermo Fisher Scientific Inc (NYSE:TMO) is one of the 785 companies in the GICS Health Care sector, and a constituent of the 33 company Life Sciences Tools & Services GICS industry group within this sector.